Barely Significant
← all excerpts

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

J Am Heart Assoc · 2019 · PMC6759901 · PMID 31423921

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a statistical trendP =0.07so close (0.05 < p ≤ 0.1)
The rise in cFGF23 between 50 weeks and baseline assessed by contrast analysis was significant in the EPO hemoglobin‐rise group ( P =0.03) and a statistical trend in the EPO hemoglobin‐stable group ( P =0.07), whereas the decline of cFGF23 levels in the control group was not significant ( P =0.53).

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.